Status:
COMPLETED
A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
40-75 years
Phase:
PHASE2
Brief Summary
A clinical study to evaluate the efficacy and safety of MK0633 in patients with Chronic Obstructive Pulmonary Disease (COPD).
Eligibility Criteria
Inclusion
- Documented COPD defined by clinical history and spirometry, with symptoms including dyspnea, wheezing, chest tightness, cough, sputum production, or nocturnal awakening
- Male or postmenopausal females 40 -75 years of age
Exclusion
- Impaired renal function
- History of chronic liver disease or persistent liver function test (LFT) abnormalities
- History of recent cardiovascular clinical event
- Evidence of another clinically significant, active pulmonary disorder such as bronchiectasis or asthma
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT00418613
Start Date
January 1 2008
End Date
March 1 2009
Last Update
September 3 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.